Fundraising Fox
🦊/Companies
Sign in

Breakthru Medicine

1 known investors

Find your way into Breakthru Medicine

Breakthru is a drug development company that applies medicinal chemistry expertise to accelerate the discovery of breakthrough medicines, emphasizing data-driven decision-making about compound viability.

BiotechDeep TechHealthtech

Investors · 1

Eshelman Ventures, LLCWilmingtonvia Fred Eshelman · inferred

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Phoenix biotech startup emerges with $60M in backing to develop cancer therapies - Flinn Foundationflinn.org · Feb 2026Breakthru Medicine Raises $60M to Tackle 'Undruggable' Cancers | Founderland | Founderlanddreamwelltimes.com · Feb 2026Breakthru Medicine emerges from stealth with $60M Series A for cancer drug development | Phoenix Bioscience Corephoenixbiosciencecore.com · Feb 2026Pipeline cuts for Sanofi; Breakthru Medicine raises $60Mendpoints.news · Jan 2026Breakthru Medicine Raises $60M in Series A Fundingfinsmes.com · Jan 2026Breakthru Medicine's - BIO Investment & Growth Summit 2026bigs.bio.org

Frequently asked questions

What does Breakthru Medicine do?
Breakthru is a drug development company that applies medicinal chemistry expertise to accelerate the discovery of breakthrough medicines, emphasizing data-driven decision-making about compound viability.
Who are Breakthru Medicine's investors?
Breakthru Medicine's investors include Eshelman Ventures, LLC.